Takayuki Hishiki Selected Research

Takayuki Hishiki Research Topics

Disease

17	Infections 01/2024 - 11/2010
3	COVID-19 10/2023 - 01/2022
3	Dengue (Dengue Fever) 12/2019 - 01/2016
2	Smallpox (Variola) 01/2023 - 01/2023
2	Hepatitis C 11/2018 - 09/2018
2	Virus Diseases (Viral Diseases) 11/2018 - 05/2015
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2024
1	Thrombosis (Thrombus) 10/2023
1	Inflammation (Inflammations) 10/2023
1	Critical Illness (Critically Ill) 10/2023
1	Zoonoses 01/2023
1	Severe Acute Respiratory Syndrome 09/2020
1	Hepatitis A (Hepatitis, Infectious) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2018
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Fatty Liver 07/2011
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2011
1	Hepatocellular Carcinoma (Hepatoma) 07/2011
1	Liver Diseases (Liver Disease) 07/2011
1	Chronic Hepatitis C 07/2011
1	T-Cell Leukemia (Leukemia, T Cell) 09/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2007

Drug/Important Bio-Agent (IBA)

13	Antiviral Agents (Antivirals)IBA 12/2022 - 05/2014
6	VaccinesIBA 12/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2007
3	LuciferasesIBA 12/2022 - 01/2014
2	InterferonsIBA 01/2024 - 01/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 09/2020
2	tecovirimatIBA 01/2023 - 01/2023
2	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023 - 01/2023
2	brincidofovirIBA 01/2023 - 01/2023
1	Interferon Type IIBA 01/2024
1	Small Interfering RNA (siRNA)IBA 01/2024
1	Ubiquitin-Specific ProteasesIBA 01/2024
1	Monoclonal AntibodiesIBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	Complement Factor B (Factor B)IBA 10/2023
1	Complement Factor D (Factor D)IBA 10/2023
1	ProteomeIBA 10/2023
1	Gemcitabine FDA Link 01/2023
1	Trifluridine (Viroptic)FDA LinkGeneric 01/2023
1	R 121919IBA 12/2022
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 12/2022
1	N- (1- ethylpropyl)- (3- methoxy- 5- (2- methoxy- 4- trifluoromethoxyphenyl)- 6- methyl- pyrazin- 2- yl)amineIBA 12/2022
1	Subgenomic RNAIBA 12/2022
1	CP 154526IBA 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	EnzymesIBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	PhytochemicalsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	PolyphenolsIBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2022
1	TeaIBA 01/2022
1	N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA 09/2020
1	Apolipoproteins E (ApoE)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2018
1	Antimalarials (Antimalarial Agents)IBA 09/2018
1	hirsutineIBA 01/2017
1	Apolipoproteins B (ApoB)IBA 10/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2014
1	YYA-021IBA 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 12/2013
1	Viral RNAIBA 12/2013
1	A-factor (Streptomyces)IBA 07/2011
1	Lipoproteins (Lipoprotein)IBA 07/2011
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 11/2010
1	Lipase (Acid Lipase)FDA Link 11/2010
1	tax Gene Products (tax Gene Product)IBA 09/2007
1	Cyclic AMP (AMP, Cyclic)IBA 09/2007
1	ElementsIBA 09/2007
1	Carrier Proteins (Binding Protein)IBA 09/2007